Norway· NO-ID_04F44639-A9E7-44E5-B092-9B6D0BC0F8AA
Carisoprodol oxford
A carisoprodol product containing karisoprodol, registered in Norway by Oxford Pharmaceuticals. The same ATC class is registered in 3 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Carisoprodol is registered in 3 of 19 countries.
Countries holding a registration under ATC M03BA02 (carisoprodol), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 2 of them publish a price we can compare per daily dose
Carisoprodol · ATC M03BA02
3 / 19 countries
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of carisoprodol costs, country by country.
Normalised to the WHO defined daily dose (1.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Carisoprodol · price per daily dose (1.4 g)
USD · FX 28 Sept 2026
- US United States$0.28 (acquisition cost)
The record
At a glance
FEST (Norway)- Active substance
- Karisoprodol
- Manufacturer
- Oxford Pharmaceuticals
- Country
- Norway (NO)
- ATC code
- M03BA02
- ATC class
- Carisoprodol
- Defined daily dose
- 1.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_04F44639-A9E7-44E5-B092-9B6D0BC0F8AA
- no_varenummer204401100
- gtin369584111107
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
214 interactions on record for carisoprodol.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Carisoprodol · interactions on record
214 records
- 4 severe
- 67 moderate
- 2 minor
- 141 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Carisoprodol in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa07fb24-8ab3-4480-be00-958b87819582 GET /v1/drugs/aa07fb24-8ab3-4480-be00-958b87819582?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Karisoprodol",
"merkevare_id": "ID_04F44639-A9E7-44E5-B092-9B6D0BC0F8AA",
"name_form_strength": "Carisoprodol oxford tab 350 mg",
"prescription_group": "A"
}See everything about carisoprodol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.